osteoarthritis knee treatment | osteoarthritis of the knee | osteoarthritis knee | osteoarthritis of knee | treatment for osteoarthritis of the knee | knee arthritis treatment | treatment for osteoarthritis knee | treatment for osteoarthritis | osteoarthritis of the knee treatment | treatment for osteoarthritis of knee | osteoarthritis in the knee | osteoarthritis knee exercises | osteoarthritis of knee treatment | treatments for osteoarthritis

message afi_india@rediffmail.com

call us +91-9818605533, 9873114480

Oesteroporosis

What is Osteoporosis?

Osteoporosis is a disease in which the density and quality of bone is reduced, leading to weakness of the skeleton and increased risk of fracture, particularly of the spine, wrist, hip, pelvis and upper arm. Osteoporosis and associated fractures are an important cause of mortality and morbidity.

In many affected people, bone loss is gradual and without warning signs until the disease is advanced. Osteoporosis is also known as "the silent crippler" because a person usually doesn't know they have it until it's too late. Unfortunately, in many cases, the first real "symptom" is a broken bone. Loss of height – with gradual curvature of the back (caused by vertebral compression fractures) may be the only physical sign of osteoporosis.

Osteoporosis: not just an "old woman's" disease

Osteoporosis is a widespread public health problem. The costs to national healthcare systems from osteoporosis-related hospitalization are staggering.

Even so, osteoporosis was not precisely defined as a disease until 1994. The World Health Organization (WHO) has since identified osteoporosis as a priority health issue along with other major non-communicable diseases.

Rapid progress is being made in the Diagnosis and Treatment of osteoporosis. Early detection of bone loss is key to the prevention of suffering and escalation of health care costs. Bone mineral density (BMD) measurements are effective in assessing fracture risk, confirming a diagnosis of osteoporosis and monitoring the effect of treatment. A major concern is that access to measuring equipment and qualified technical personnel – and reimbursement by medical insurance schemes – remain inadequate in a great many countries.